Sprinklr (CXM) Tops Q4 EPS by 4c, Beats on Revenue; Offers FY27 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| Cardium Therapeutics, Inc. (NYSE: CXM) | Delayed: 6.83 +0.12 (1.79%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.71 | 52 Week High | $1.44 | |||
| Open | $6.89 | 52 Week Low | $0.06 | |||
| Day High | $7.00 | P/E | N/A | |||
| Day Low | $6.78 | EPS | $-1.24 | |||
| Volume | 1,161,615 | |||||
